News
After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...
1h
Week99er on MSNTop 3 Cryptos to Accumulate for 2025, One Has a 300% Path AheadThe narrative for 2025 is forming fast: low-entry tokens with actual utility and protocol depth are taking center stage. While familiar names like Ethereum (ETH), Solana (SOL), and Chainlink (LINK) ...
New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...
Jazz Pharmaceuticals plc is a Buy with its robust portfolio, potential FDA approvals, and innovative oncology treatments.
Silver is getting very close to a mania phase based on signals from the Dow/gold ratio previously presented. Click to read.
Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral ...
A proposed layout for the initial phase of Rochester’s planned sports and recreation complex has been finalized.
A former top bureaucrat who worked closely with Treasurer Jim Chalmers wants boomers to be hit with a new tax on their ...
5h
Cryptopolitan on MSNBest Cryptocurrencies to Load Up On This July Before They MoonThe countdown to the next market breakout has already begun, and July is shaping up to be a defining moment for crypto ...
DU UG Admission 2025: The Delhi University has announced the schedule for Phase 2 of the Common Seat Allocation System (CSAS) ...
The Indian Institutes of Technology (IITs) are reshaping their academic offerings by phasing out traditional five-year dual ...
New Delhi: The proposed India-US bilateral agreement (BTA) is not likely to resolve the fraught issue of American tariffs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results